RxSight (RXST) Change in Account Payables (2020 - 2026)
RxSight's (RXST) quarterly Change in Account Payables came in at $1.6 million in Q1 2026, down 29.16% YoY from $2.2 million in Q1 2025, and down 28.45% on a QoQ basis from $2.2 million in Q4 2025.
RxSight (RXST) Change in Account Payables (2020 - 2026) Analysis & Trends
RxSight (RXST) has 7 years of Change in Account Payables data on file, last reported at $1.6 million in Q1 2026.
- Quarterly Change in Account Payables fell 29.16% year-over-year to $1.6 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was -$22000.0 (down 101.1% YoY) and the FY2025 annual result came in at $627000.0, down 33.72% from the prior year.
- Change in Account Payables declined to $1.6 million in Q1 2026, from $2.2 million in the prior quarter.
- In the past five years, Change in Account Payables ranged from a high of $2.2 million in Q1 2025 to a low of -$3.7 million in Q2 2025.
- A 5-year average of $296176.5 and a median of $161000.0 in 2023 frame the typical range for Change in Account Payables.
- Annual changes were most pronounced in 2022 — Change in Account Payables plunged 1779.21% — and 2025, when it surged 1800.0%.
- Tracing RXST's Change in Account Payables over 5 years: stood at -$1.7 million in 2022, then jumped by 90.68% to -$158000.0 in 2023, then surged by 173.42% to $116000.0 in 2024, then surged by 1800.0% to $2.2 million in 2025, then slipped by 28.45% to $1.6 million in 2026.
- The last three Change in Account Payables figures came in at $1.6 million (Q1 2026), $2.2 million (Q4 2025), and -$86000.0 (Q3 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Change in Account Payables (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 198.70 Bn | 193.10 Bn | 7.27 Bn | - |
| 2 | Stryker | 125.85 Bn | 122.37 Bn | 4.50 Bn | 71.00 Mn |
| 3 | Medtronic | 118.44 Bn | 109.22 Bn | 6.41 Bn | - |
| 4 | Boston Scientific | 72.64 Bn | 72.10 Bn | 3.85 Bn | - |
| 5 | Edwards Lifesciences | 51.94 Bn | 47.69 Bn | 1.35 Bn | - |
| 6 | Dexcom | 34.48 Bn | 32.53 Bn | 830.00 Mn | - |
| 7 | GE HealthCare Technologies | 33.60 Bn | 31.49 Bn | 2.18 Bn | -200.00 Mn |
| 8 | Koninklijke Philips | 26.30 Bn | 22.98 Bn | 4.55 Bn | - |
| 9 | Steris | 23.00 Bn | 22.52 Bn | 684.20 Mn | 4.30 Mn |
| 10 | RxSight | 250.81 Mn | -153.43 Mn | - | -631,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | -631,000.00 |
| Jun 30, 2026 | -631,000.00 |
| Mar 31, 2026 | 1.58 Mn |
| Mar 31, 2026 | 1.58 Mn |
| Dec 31, 2025 | 2.20 Mn |
| Dec 31, 2025 | 2.20 Mn |
| Sep 30, 2025 | -86,000.00 |
| Sep 30, 2025 | -86,000.00 |
| Jun 30, 2025 | -3.72 Mn |
| Jun 30, 2025 | -3.72 Mn |
| Mar 31, 2025 | 2.23 Mn |
| Mar 31, 2025 | 2.23 Mn |
| Dec 31, 2024 | 116,000.00 |
| Dec 31, 2024 | 116,000.00 |
| Sep 30, 2024 | 41,000.00 |
| Sep 30, 2024 | 41,000.00 |
| Jun 30, 2024 | -387,000.00 |
| Jun 30, 2024 | -387,000.00 |
| Mar 31, 2024 | 1.18 Mn |
| Mar 31, 2024 | 1.18 Mn |